1. Complement System: Promoter or Suppressor of Cancer Progression?
   Margot Revel et al, 2020, Antibodies CrossRef
2. Protein Corona Gold Nanoparticles Fingerprinting Reveals a Profile of Blood Coagulation Proteins in the Serum of HER2-Overexpressing Breast Cancer Patients
   María del Pilar Chantada-Vázquez et al, 2020, International Journal of Molecular Sciences CrossRef
3. A bacterial tyrosine phosphatase modulates cell proliferation through targeting RGCC
   Chengcheng Liu et al, 2021, PLOS Pathogens CrossRef
4. Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
   Stephanie Downs-Canner et al, 2016, Annals of Surgical Oncology CrossRef
5. RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC
   Xiao-Yan Wang et al, 2017, Scientific Reports CrossRef
6. Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects against Pulmonary Fibrosis
   Irina G. Luzina et al, 2022, American Journal of Respiratory Cell and Molecular Biology CrossRef
7. Complement and Cancer—A Dysfunctional Relationship?
   Joshua M. Thurman et al, 2020, Antibodies CrossRef
8. Response gene to complement‑32 promotes cell survival via the NF‑κB pathway in non‑small‑cell lung cancer
   Jing Zhang et al, 2019, Experimental and Therapeutic Medicine CrossRef
9. Regulation mechanism of PDK1 on macrophage metabolism and function
   Yueqin Yang et al, 2016, Cell Biochemistry and Function CrossRef
10. Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer
    Trisha A. Rettig et al, 2015, Clinical Immunology CrossRef
11. A review of human diseases caused or exacerbated by aberrant complement activation
    Patrick L. McGeer et al, 2017, Neurobiology of Aging CrossRef
12. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis
    Hongmei Gu et al, 2016, The FASEB Journal CrossRef
13. RGC-32 induces transition of pancreatic cancer to epithelial mesenchyme in vivo
    Liang Zhu et al, 2018, Pancreatology CrossRef
14. RGC-32 and diseases: the first 20 years
    Sonia I. Vlaicu et al, 2019, Immunologic Research CrossRef
15. High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
    Wei Xi et al, 2016, Scientific Reports CrossRef
16. Le système du complément
    Marie Daugan et al, 2017, médecine/sciences CrossRef
17. Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32
    Michèle Brocard et al, 2018, Nucleic Acids Research CrossRef
18. Oncogenic gene RGC‐32 is a direct target of miR‐26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling
    Zhong‐Heng Yang et al, 2020, Cell Biochemistry and Function CrossRef
19. By Increasing the Expression and Activation of STAT3, Sustained C5a Stimulation Increases the Proliferation, Migration, and Invasion of RCC Cells and Promotes the Growth of Transgrafted Tumors
    Jing-Min Zheng et al, 2021, Cancer Management and Research CrossRef
20. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression
    Jian Chen et al, 2018, Cancer Letters CrossRef
21. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation
    Chenhui Zhao et al, 2018, Oncogene CrossRef
22. Enhancement of cancer invasion and growth via the C5a‑C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion
    Masakazu Yoneda et al, 2018, Oncology Letters CrossRef
23. Expression of RGC32 in human normal and preeclamptic placentas and its role in trophoblast cell invasion and migration
    Q.-j. Wang et al, 2015, Placenta CrossRef
24. Anaphylatoxins Enhance Recruitment of Nonclassical Monocytes via Chemokines Produced by Pleural Mesothelial Cells in Tuberculous Pleural Effusion
    Lisha Luo et al, 2019, American Journal of Respiratory Cell and Molecular Biology CrossRef
25. Complementing the Cancer-Immunity Cycle
    Ruben Pio et al, 2019, Frontiers in Immunology CrossRef